KALV- Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palleiko Benjamin L	462.6K	$12.36M	-9,550
Other	Yea Christopher	223.5K	$5.97M	-
Other	Audhya Paul K.	142.5K	$3.81M	-2,686
Other	Arif Bilal	100.0K	$2.67M	-
Other	Sweeny Nicole	51.4K	$1.37M	-1,862

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 17, 2026	Palleiko Benjamin L48	Chief Executive Officer	Sale+OE	9,550	$20.22	$193,065.67	-2.0%	-	-
Apr 17, 2026	Audhya Paul K.46	Chief Medical Officer	Sale+OE	2,686	$20.22	$54,300.98	-1.8%	-	-
Apr 17, 2026	Piekos Brian	Chief Financial Officer	Sale+OE	1,862	$20.22	$37,642.75	-9.3%	-	-
Apr 17, 2026	Sweeny Nicole	Chief Commercial Officer	Sale+OE	1,862	$20.22	$37,642.75	-3.5%	-	-
Dec 8, 2025	Palleiko Benjamin L48	Chief Executive Officer	Sale+OE	7,294	$16.51	$120,423.94	-1.7%	+2.6%	-
Nov 24, 2025	Sweeny Nicole	Chief Commercial Officer	Sale+OE	3,813	$13.45	$51,288.66	-8.8%	+16.5%	-
Nov 24, 2025	Piekos Brian	Chief Financial Officer	Sale+OE	4,471	$13.45	$60,139.42	-29.8%	+16.5%	-
Nov 24, 2025	Yea Christopher55	Chief Development Officer	Sale+OE	4,331	$13.45	$58,256.28	-1.9%	+16.5%	-
Nov 24, 2025	Audhya Paul K.46	Chief Medical Officer	Sale+OE	5,296	$13.45	$71,236.50	-3.9%	+16.5%	-
Nov 24, 2025	Palleiko Benjamin L48	Chief Executive Officer	Sale+OE	10,940	$13.45	$147,153.94	-2.6%	+16.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC